QSQuantSignals Research/Scion Template
Try FST free

QS Research · Michael Burry's Scion Capital analyst template · 2006

Constellation Energy Corp (CEG)

As of 2026-11-06 · 11/15 boxes filled from SEC filings and market data

Conclusion: PASS

Conviction low · base case 0% · downside -23% · upside +22%

The market is not missing the operating recovery: TTM to Jun 30 2026 EBIT is $4.60B, EBITDA $8.27B and net income $3.46B, above FY2025, and FY2026 adjusted EPS guidance was raised to $11.50-$12.50. What it is doing is refusing to pay a premium utility multiple for merchant cash flow: at $249.95 CEG is 25.6x TTM P/E, 12.9x EV/EBITDA and 0.3% FCF yield, with $2.52B of TTM buybacks/dividends versus $309.0M FCF and $19.11B debt. Base case at 12.9x $8.27B EBITDA is $106.97B EV and $88.56B equity, 0% vs price; 10.5x gives about $192 (-23%) and 15.4x gives about $306 (+22%), roughly 1:1 reward/risk. No cycle-average normalization is used; all three cases use TTM to Jun 30 2026. Verdict pass: the sector de-rating is real, but there is no margin of safety and the long/short rule is not met.

Key numbers

The 15 boxes

  1. ✓ 1. Long-form business notes

    CEG's revenue engine in the sources is a generating fleet sold through PPAs and merchant spot markets, plus competitive retail supply to C&I, government and residential customers; approximately 70% of generating resources sit in PJM. FY2025 revenue was $22.66B, operating income $3.09B, net income $2.32B, operating cash flow $4.24B and capex $2.95B. The FY2021-to-FY2025 XBRL shows revenue rising from $17.25B to $22.66B while operating income and operating cash flow swung sharply. The latest 10-K adds the January 2026 Calpine acquisition and the IRA/OBBBA nuclear PTC; the sources do not provide segment-level revenue or margin detail.

  2. ○ 2. Competitive advantage

    CEG's claimed moat is scale plus 25 nuclear units (22 GW, 183 TWh in 2025, 94.7% capacity factor), licences it intends to extend to 80 years, and state/federal policy support (ZEC/CMC programs, nuclear PTC) that management says states cannot meet their goals without. The financial record does not yet confirm durable margins: operating income was -$346.0M in FY2021 and only turned materially positive in FY2023 ($1.61B), $4.35B in FY2024 and $3.09B in FY2025, and operating cash flow was negative in every year FY2021-FY2024 before +$4.24B in FY2025. These sources name no competitors, give no margin percentages or returns, and show the advantage is licence- and policy-contingent.

  3. ✓ 3. 10-Q takeaways

    Q2 2026 revenue was $7,504M, up 23.0% from $6,101M, but GAAP net income attributable to common shareholders fell to $513M from $839M; adjusted operating earnings rose to $920M from $599M, so the GAAP quarter carried large unrealized fair-value and Calpine-related items. Six-month revenue was $18,626M, up 44.5%, with adjusted operating earnings of $1,893M versus $1,272M. Liquidity was $7.0B of credit capacity plus $0.7B cash at June 30, 2026; the key 10-Q items are Calpine integration/divestitures, PJM capacity outcomes, data-center/PPA contracts, nuclear outages and fuel/regulatory risks.

  4. ✓ 4. Corporate governance

    Filled; members read this box.

  5. ✓ 5. Overview of the prior 3 years of 8-K filings

    Filled; members read this box.

  6. ✓ 6. Other significant filings

    Filled; members read this box.

  7. ✓ 7. Chronology of significant news and events

    Filled; members read this box.

  8. ✓ 8. Comparables valuation interpretation

    Filled; members read this box.

  9. ✓ 9. Insider trading interpretation

    Filled; members read this box.

  10. ○ 10. Earnings-call notes
  11. ○ 11. Impression of the shareholder letter
  12. ○ 12. Scuttlebutt overview
  13. ✓ 13. Valuation and risk/reward summary

    Filled; members read this box.

  14. ✓ 14. Current price suppression and potential catalysts

    Filled; members read this box.

  15. ✓ 15. Conclusions

    The call above.

Sign in with a QuantSignals Premium or Gold plan to read every box: each point linked to the SEC filing it came from, the bull and bear case, and the comparables. QS Research powers the signals behind FST, our autonomous trading agent.

Put these signals to work

The Scion template's preview is free. Paid members read every box of every report. FST, the QuantSignals trading agent, uses QS Research as its brain.

Join freeMeet FSTSee plans